2,3-dinor-thromboxane b2 has been researched along with sulindac in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boss, AH; Catella, F; Ciabattoni, G; Daffonchio, L; Daugherty, J; Dray, F; FitzGerald, GA; Patrono, C | 1 |
Boss, AH; Catella, F; Cibattoni, G; Filabozzi, P; Patrignani, P; Patrono, C; Pierucci, A; Pugliese, F; Simonetti, BM | 1 |
2 other study(ies) available for 2,3-dinor-thromboxane b2 and sulindac
Article | Year |
---|---|
Radioimmunoassay measurement of 2,3-dinor metabolites of prostacyclin and thromboxane in human urine.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aspirin; Blood Platelets; Female; Humans; Kidney; Male; Radioimmunoassay; Sulindac; Thromboxane B2 | 1987 |
Effects of sulindac on renal and extrarenal eicosanoid synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Administration, Oral; Adult; Epoprostenol; Female; Humans; Indenes; Kidney; Male; Radioimmunoassay; Sulindac; Thromboxane A2; Thromboxane B2 | 1987 |